SHE | Src homology 2 domain containing E | 1q21.3 | 0.501 | 0.724 | 0
|
ADCY4 | adenylate cyclase 4 | 14q11.2 | 0.468 | 0.632 | 0
|
CLEC3B | C-type lectin domain family 3, member B | 3p22-p21.3 | 0.445 | 0.658 | 0
|
CNRIP1 | cannabinoid receptor interacting protein 1 | 2p13 | 0.442 | 0.61 | 0
|
GRASP | GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein | 12q13.13 | 0.441 | 0.663 | 0
|
AQP1 | aquaporin 1 (Colton blood group) | 7p14 | 0.433 | 0.559 | 0
|
ECSCR | endothelial cell surface expressed chemotaxis and apoptosis regulator | 5q31.2 | 0.431 | 0.602 | 0
|
CCL14 | chemokine (C-C motif) ligand 14 | 17q12 | 0.431 | 0.612 | 0
|
JAM2 | junctional adhesion molecule 2 | 21q21.2 | 0.418 | 0.622 | 0
|
OLFM1 | olfactomedin 1 | 9q34.3 | 0.414 | 0.601 | 0
|
RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 11q13 | 0.412 | 0.668 | 0
|
USHBP1 | Usher syndrome 1C binding protein 1 | 19p13.11 | 0.409 | 0.603 | 0
|
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 7p13-p12 | 0.407 | 0.599 | 0
|
EMCN | endomucin | 4q22.1 | 0.403 | 0.563 | 0
|
CCM2L | cerebral cavernous malformation 2-like | 20q11.21 | 0.403 | 0.65 | 0
|
JAM3 | junctional adhesion molecule 3 | 11q25 | 0.401 | 0.575 | 0
|
EBF1 | early B-cell factor 1 | 5q34 | 0.4 | 0.605 | 0
|
TNS2 | tensin 2 | 12q13.13 | 0.394 | 0.594 | 0
|
ACKR1 | atypical chemokine receptor 1 (Duffy blood group) | 1q21-q22 | 0.392 | 0.599 | 0
|
KLF2 | Kruppel-like factor 2 | 19p13.11 | 0.392 | 0.619 | 0
|
GJA4 | gap junction protein, alpha 4, 37kDa | 1p35.1 | 0.391 | 0.557 | 0
|
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 17q12-q21.1 | 0.39 | 0.586 | 0
|
ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | 19p13.2 | 0.387 | 0.584 | 0
|
GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 7q31-q32 | 0.386 | 0.604 | 0
|
MEOX1 | mesenchyme homeobox 1 | 17q21.31 | 0.385 | 0.562 | 0
|
LRRC70 | leucine rich repeat containing 70 | 5q12.1 | 0.383 | 0.528 | 0
|
CD1D | CD1d molecule | 1q23.1 | 0.382 | 0.541 | 0
|
LINC00341 | long intergenic non-protein coding RNA 341 | 14q32.13 | 0.382 | 0.55 | 0
|
CD79B | CD79b molecule, immunoglobulin-associated beta | 17q23 | 0.379 | 0.578 | 0
|
HSPA12B | heat shock 70kD protein 12B | 20p13 | 0.379 | 0.587 | 0
|
GNG7 | guanine nucleotide binding protein (G protein), gamma 7 | 19p13.3 | 0.378 | 0.602 | 0
|
FAM107A | family with sequence similarity 107, member A | 3p14.2 | 0.377 | 0.6 | 0
|
ADRA2A | adrenoceptor alpha 2A | 10q25.2 | 0.377 | 0.549 | 0
|
PTH1R | parathyroid hormone 1 receptor | 3p22-p21.1 | 0.377 | 0.589 | 0
|
ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 17p13.1 | 0.376 | 0.511 | 0
|
GYPC | glycophorin C (Gerbich blood group) | 2q14-q21 | 0.375 | 0.591 | 0
|
STARD8 | StAR-related lipid transfer (START) domain containing 8 | Xq13.1 | 0.375 | 0.57 | 0
|
EBF3 | early B-cell factor 3 | 10q26.3 | 0.371 | 0.565 | 0
|
SOBP | sine oculis binding protein homolog | 6q21 | 0.371 | 0.528 | 0
|
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 15q24-q25 | 0.371 | 0.567 | 0
|
GIMAP1 | GTPase, IMAP family member 1 | 7q36.1 | 0.367 | 0.546 | 0
|
SCN1B | sodium channel, voltage gated, type I beta subunit | 19q13.12 | 0.367 | 0.576 | 0
|
KANK3 | KN motif and ankyrin repeat domains 3 | 19p13.2 | 0.365 | 0.537 | 0
|
ITM2A | integral membrane protein 2A | Xq13.3-q21.2 | 0.363 | 0.559 | 0
|
SEMA3G | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G | 3p21.1 | 0.361 | 0.53 | 0
|
CFP | complement factor properdin | Xp11.4 | 0.358 | 0.587 | 0
|
ITGA7 | integrin, alpha 7 | 12q13 | 0.357 | 0.558 | 0
|
FGF13 | fibroblast growth factor 13 | Xq26.3 | 0.356 | 0.47 | 0
|
TAL1 | T-cell acute lymphocytic leukemia 1 | 1p32 | 0.354 | 0.552 | 0
|
CD300LG | CD300 molecule-like family member g | 17q21.31 | 0.351 | 0.509 | 0
|
RBP5 | retinol binding protein 5, cellular | 12p13.31 | 0.35 | 0.516 | 0
|
TACR1 | tachykinin receptor 1 | 2p13.1-p12 | 0.349 | 0.579 | 0
|
SOX18 | SRY (sex determining region Y)-box 18 | 20q13.33 | 0.348 | 0.542 | 0
|
MICU3 | mitochondrial calcium uptake family, member 3 | 8p22 | 0.348 | 0.472 | 0
|
MEG3 | maternally expressed 3 (non-protein coding) | 14q32.2 | 0.347 | 0.514 | 0
|
C16orf89 | chromosome 16 open reading frame 89 | 16p13.3 | 0.347 | 0.521 | 0
|
PKDCC | protein kinase domain containing, cytoplasmic | 2p21 | 0.344 | 0.52 | 0
|
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 4q23 | 0.34 | 0.474 | 0
|
SOX8 | SRY (sex determining region Y)-box 8 | 16p13.3 | 0.337 | 0.505 | 0
|
CYP21A2 | cytochrome P450, family 21, subfamily A, polypeptide 2 | 6p21.3 | 0.336 | 0.554 | 0
|
MSX1 | msh homeobox 1 | 4p16.2 | 0.336 | 0.493 | 0
|
CUBN | cubilin (intrinsic factor-cobalamin receptor) | 10p12 | 0.333 | 0.468 | 0
|
AVPR2 | arginine vasopressin receptor 2 | Xq28 | 0.331 | 0.522 | 0
|
ADORA2A | adenosine A2a receptor | 22q11.23 | 0.328 | 0.496 | 0
|
GFRA1 | GDNF family receptor alpha 1 | 10q25-q26 | 0.325 | 0.448 | 0
|
NRROS | negative regulator of reactive oxygen species | 3q29 | 0.324 | 0.522 | 0
|
DUSP26 | dual specificity phosphatase 26 (putative) | 8p12 | 0.324 | 0.568 | 0
|
A1BG | alpha-1-B glycoprotein | 19q13.43 | 0.319 | 0.372 | 1.85e-15
|
TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 17p11.2 | 0.316 | 0.405 | 0
|
CYP46A1 | cytochrome P450, family 46, subfamily A, polypeptide 1 | 14q32.2 | 0.314 | 0.505 | 0
|
TOX2 | TOX high mobility group box family member 2 | 20q13.12 | 0.31 | 0.507 | 0
|
RRN3P2 | RRN3 homolog, RNA polymerase I transcription factor pseudogene 2 | 16p11.2 | 0.31 | 0.483 | 0
|
CXCR5 | chemokine (C-X-C motif) receptor 5 | 11q23.3 | 0.308 | 0.372 | 1.72e-15
|
FAM129C | family with sequence similarity 129, member C | 19p13.11 | 0.308 | 0.479 | 0
|
LTC4S | leukotriene C4 synthase | 5q35 | 0.306 | 0.473 | 0
|
CHMP4C | charged multivesicular body protein 4C | 8q21.13 | 0.305 | -0.478 | 0
|
FAM124A | family with sequence similarity 124A | 13q14.3 | 0.304 | 0.44 | 0
|
MUSTN1 | musculoskeletal, embryonic nuclear protein 1 | 3p21.31 | 0.301 | 0.52 | 0
|
MAPK11 | mitogen-activated protein kinase 11 | 22q13.33 | 0.301 | 0.412 | 0
|
SUSD5 | sushi domain containing 5 | 3p23 | 0.301 | 0.435 | 0
|
TSPAN7 | tetraspanin 7 | Xp11.4 | 0.3 | 0.476 | 0
|
KCNK3 | potassium channel, two pore domain subfamily K, member 3 | 2p23 | 0.3 | 0.504 | 0
|
MYO7B | myosin VIIB | 2q21.1 | 0.299 | 0.336 | 1.37e-12
|
PDZD4 | PDZ domain containing 4 | Xq28 | 0.298 | 0.53 | 0
|
CRMP1 | collapsin response mediator protein 1 | 4p16.1 | 0.295 | 0.471 | 0
|
KLHL14 | kelch-like family member 14 | 18q12.1 | 0.293 | 0.487 | 0
|
KIAA2022 | KIAA2022 | Xq13.3 | 0.292 | 0.409 | 0
|
LINC00092 | long intergenic non-protein coding RNA 92 | 9q22.32 | 0.291 | 0.502 | 0
|
ARHGAP32 | Rho GTPase activating protein 32 | 11q24.3 | 0.288 | -0.411 | 0
|
FAM43B | family with sequence similarity 43, member B | 1p36.12 | 0.287 | 0.478 | 0
|
RBP7 | retinol binding protein 7, cellular | 1p36.22 | 0.286 | 0.513 | 0
|
TSPAN32 | tetraspanin 32 | 11p15 | 0.285 | 0.389 | 0
|
GPD2 | glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | 2q24.1 | 0.285 | -0.466 | 0
|
ADD2 | adducin 2 (beta) | 2p13.3 | 0.285 | 0.36 | 2.04e-14
|
GRHL2 | grainyhead-like transcription factor 2 | 8q22.3 | 0.285 | -0.421 | 0
|
RNF122 | ring finger protein 122 | 8p12 | 0.283 | 0.396 | 0
|
ANKRD53 | ankyrin repeat domain 53 | 2p13.3 | 0.283 | 0.464 | 0
|
CPLX1 | complexin 1 | 4p16.3 | 0.282 | 0.409 | 0
|
PRPH | peripherin | 12q12-q13 | 0.281 | 0.539 | 0
|
IRF6 | interferon regulatory factor 6 | 1q32.2-q32.3 | 0.281 | -0.397 | 0
|
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 19p13.3 | 0.279 | 0.431 | 0
|
SLK | STE20-like kinase | 10q25.1 | 0.279 | -0.268 | 2.19e-08
|
PTPRF | protein tyrosine phosphatase, receptor type, F | 1p34 | 0.278 | -0.42 | 0
|
LTF | lactotransferrin | 3p21.31 | 0.277 | 0.455 | 0
|
ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | 20p12.2 | 0.276 | -0.408 | 0
|
CTNND1 | catenin (cadherin-associated protein), delta 1 | 11q12.1 | 0.274 | -0.392 | 0
|
VPS4B | vacuolar protein sorting 4 homolog B (S. cerevisiae) | 18q21.33 | 0.274 | -0.321 | 1.43e-11
|
KLF5 | Kruppel-like factor 5 (intestinal) | 13q21.3 | 0.273 | -0.409 | 0
|
C2CD4B | C2 calcium-dependent domain containing 4B | 15q22.2 | 0.272 | 0.463 | 0
|
GPR146 | G protein-coupled receptor 146 | 7p22.3 | 0.271 | 0.474 | 0
|
ZNF467 | zinc finger protein 467 | 7q36.1 | 0.27 | 0.416 | 0
|
PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 11q12 | 0.269 | 0.444 | 0
|
GPER1 | G protein-coupled estrogen receptor 1 | 7p22 | 0.269 | 0.414 | 0
|
DNASE1L3 | deoxyribonuclease I-like 3 | 3p14.3 | 0.267 | 0.456 | 0
|
FIGNL2 | fidgetin-like 2 | 12q13.13 | 0.267 | 0.377 | 5.09e-16
|
ALPL | alkaline phosphatase, liver/bone/kidney | 1p36.12 | 0.267 | 0.403 | 0
|
LAT | linker for activation of T cells | 16q13 | 0.266 | 0.421 | 0
|
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 12q23.1 | 0.266 | 0.445 | 0
|
SRSF12 | serine/arginine-rich splicing factor 12 | 6q16.1 | 0.264 | 0.44 | 0
|
DPY19L2 | dpy-19-like 2 (C. elegans) | 12q14.2 | 0.261 | 0.419 | 0
|
SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 11p13-p12 | 0.261 | 0.431 | 0
|
FAM83B | family with sequence similarity 83, member B | 6p12.1 | 0.26 | -0.332 | 2.45e-12
|
RIPK4 | receptor-interacting serine-threonine kinase 4 | 21q22.3 | 0.26 | -0.354 | 6.65e-14
|
MTMR9LP | myotubularin related protein 9-like, pseudogene | 1p35.1 | 0.26 | 0.409 | 0
|
MAGEH1 | melanoma antigen family H1 | Xp11.22 | 0.259 | 0.441 | 0
|
TENM1 | teneurin transmembrane protein 1 | Xq25 | 0.256 | 0.089 | 0.0677
|
KCNIP3 | Kv channel interacting protein 3, calsenilin | 2q21.1 | 0.256 | 0.37 | 2.92e-15
|
GPBP1L1 | GC-rich promoter binding protein 1-like 1 | 1p34.1 | 0.255 | -0.374 | 1.11e-15
|
LOC100499484-C9ORF174 | | | 0.255 | 0.375 | 8.76e-16
|
A2M-AS1 | A2M antisense RNA 1 (head to head) | 12p13.31 | 0.254 | 0.494 | 0
|
MYCBP | MYC binding protein | 1p33-p32.2 | 0.254 | -0.318 | 2.13e-11
|
SLC25A24 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 | 1p13.2 | 0.253 | -0.429 | 0
|
RHBDL3 | rhomboid, veinlet-like 3 (Drosophila) | 17q11.2 | 0.252 | 0.339 | 8.95e-13
|
TMBIM6 | transmembrane BAX inhibitor motif containing 6 | 12q13.12 | 0.252 | -0.321 | 1.38e-11
|
PHOSPHO1 | phosphatase, orphan 1 | 17q21.32 | 0.251 | 0.427 | 0
|
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 1p34.2 | 0.251 | -0.408 | 0
|
NDFIP2 | Nedd4 family interacting protein 2 | 13q22.1 | 0.251 | -0.411 | 0
|
AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | Xq22.3 | 0.25 | -0.417 | 0
|
NUP54 | nucleoporin 54kDa | 4q21.1 | 0.25 | -0.237 | 7.62e-07
|
RNF112 | ring finger protein 112 | 17p11.2 | 0.247 | 0.471 | 0
|
CUX2 | cut-like homeobox 2 | 12q24.12 | 0.247 | 0.407 | 0
|
CAPN1 | calpain 1, (mu/I) large subunit | 11q13 | 0.243 | -0.377 | 6.1e-16
|
BEGAIN | brain-enriched guanylate kinase-associated | 14q32.2 | 0.242 | 0.43 | 0
|
AVL9 | AVL9 homolog (S. cerevisiase) | 7p14.3 | 0.242 | -0.34 | 6.48e-13
|
BMPER | BMP binding endothelial regulator | 7p14.3 | 0.242 | 0.388 | 0
|
CLEC4F | C-type lectin domain family 4, member F | 2p13.3 | 0.242 | 0.411 | 0
|
HK2 | hexokinase 2 | 2p13 | 0.241 | -0.368 | 4.51e-15
|
EMID1 | EMI domain containing 1 | 22q12.2 | 0.24 | 0.341 | 5.73e-13
|
SSUH2 | ssu-2 homolog (C. elegans) | 3p25.3 | 0.238 | 0.429 | 0
|
TMEM136 | transmembrane protein 136 | 11q23.3 | 0.238 | 0.421 | 0
|
CECR6 | cat eye syndrome chromosome region, candidate 6 | 22q11.2 | 0.237 | 0.246 | 2.95e-07
|
IL11RA | interleukin 11 receptor, alpha | 9p13 | 0.237 | 0.415 | 0
|
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | 4p16.3 | 0.236 | 0.276 | 7.36e-09
|
ASRGL1 | asparaginase like 1 | 11q12.3 | 0.235 | 0.334 | 1.82e-12
|
CNTN2 | contactin 2 (axonal) | 1q32.1 | 0.234 | 0.428 | 0
|
LOC400043 | | | 0.233 | 0.257 | 8.3e-08
|
HBA2 | hemoglobin, alpha 2 | 16p13.3 | 0.232 | 0.363 | 1.14e-14
|
ANO2 | anoctamin 2, calcium activated chloride channel | 12p13.3 | 0.229 | 0.404 | 0
|
GART | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | 21q22.11 | 0.228 | -0.394 | 0
|
SYP | synaptophysin | Xp11.23-p11.22 | 0.227 | 0.387 | 0
|
LIFR | leukemia inhibitory factor receptor alpha | 5p13-p12 | 0.227 | 0.414 | 0
|
PNPLA7 | patatin-like phospholipase domain containing 7 | 9q34.3 | 0.227 | 0.429 | 0
|
UBE3C | ubiquitin protein ligase E3C | 7q36.3 | 0.227 | -0.355 | 5.04e-14
|
ZMAT1 | zinc finger, matrin-type 1 | Xq21 | 0.226 | 0.315 | 3.69e-11
|
OR2A7 | olfactory receptor, family 2, subfamily A, member 7 | 7q35 | 0.226 | -0.308 | 9.39e-11
|
ARL6IP6 | ADP-ribosylation factor-like 6 interacting protein 6 | 2q23 | 0.226 | -0.389 | 0
|
GORASP2 | golgi reassembly stacking protein 2, 55kDa | 2q31.1 | 0.223 | -0.354 | 6.35e-14
|
FBXO31 | F-box protein 31 | 16q24 | 0.222 | 0.261 | 4.83e-08
|
AGRN | agrin | 1p36.33 | 0.221 | -0.323 | 9.77e-12
|
TMEM167B | transmembrane protein 167B | 1p13.3 | 0.219 | -0.161 | 0.000836
|
HBA1 | hemoglobin, alpha 1 | 16p13.3 | 0.218 | 0.282 | 3.61e-09
|
AIF1L | allograft inflammatory factor 1-like | 9q34.13-q34.3 | 0.215 | 0.226 | 2.41e-06
|
SPTBN4 | spectrin, beta, non-erythrocytic 4 | 19q13.13 | 0.215 | 0.356 | 4.25e-14
|
HPCAL1 | hippocalcin-like 1 | 2p25.1 | 0.211 | 0.178 | 0.00022
|
DNAAF5 | dynein, axonemal, assembly factor 5 | 7p22.3 | 0.211 | -0.297 | 4.66e-10
|
KCND1 | potassium channel, voltage gated Shal related subfamily D, member 1 | Xp11.23 | 0.211 | 0.303 | 2.06e-10
|
CHRNA5 | cholinergic receptor, nicotinic, alpha 5 (neuronal) | 15q24 | 0.211 | -0.291 | 1.07e-09
|
PNMA3 | paraneoplastic Ma antigen 3 | Xq28 | 0.208 | 0.344 | 3.35e-13
|
SLC24A5 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 | 15q21.1 | 0.205 | 0.238 | 7.02e-07
|
CHD5 | chromodomain helicase DNA binding protein 5 | 1p36.3 | 0.204 | 0.382 | 1.09e-16
|
CA9 | carbonic anhydrase IX | 9p13.3 | 0.2 | -0.341 | 6.3e-13
|
USP2 | ubiquitin specific peptidase 2 | 11q23.3 | 0.196 | 0.254 | 1.11e-07
|
APH1A | APH1A gamma secretase subunit | 1q21.2 | 0.192 | -0.25 | 1.72e-07
|
KCTD5 | potassium channel tetramerization domain containing 5 | 16p13.3 | 0.19 | -0.27 | 1.68e-08
|
LINC00899 | long intergenic non-protein coding RNA 899 | 22q13.31 | 0.186 | 0.118 | 0.0149
|
MARCH3 | membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase | 5q23.2 | 0.184 | 0.156 | 0.00125
|
NIM1K | NIM1 serine/threonine protein kinase | 5p12 | 0.181 | 0.169 | 0.000476
|
C11orf45 | chromosome 11 open reading frame 45 | 11q24.3 | 0.172 | -0.18 | 0.000187
|